Introduction {#Sec1}
============

Bone cysts usually present in the pediatric population, and despite its benign nature, more than half of the cases present with pathological fracture \[[@CR1]\] and pain, which negatively affects life style, as well as causing continuous trouble for participating in sports, etc. They are one of the most common benign bone lesions in childhood, and in this respect, the problem has important social and health-related issues. Given the varied theories about their occurrence \[[@CR2]--[@CR5]\], bone cysts in the historical frame have dictated various approaches in treatment, from extremely drastic segmental resections \[[@CR6]\], intramedullary nailing \[[@CR7]\], curettage with grafting or cementing \[[@CR8]\], continuous decompression with cannulated screws \[[@CR9]\], steroid \[[@CR10]--[@CR12]\] or autogenous bone marrow injection \[[@CR13], [@CR14]\], and waiting without intervention. Retrospective analyses of these methods of treatment demonstrate no requirement for drastic approaches, and its optimization requires neither resection nor curettage.

Thus, in an attempt to improve treatment results and decrease the time needed for full recovery, our approach was to destroy the closed cystic cavity and decompress and fill it with distractive regenerative bone tissue, simultaneously eliminating limb-length discrepancy and deformities. The aim of this study was to retrospectively evaluate the effectiveness of treatment for bone cysts using the hybrid external fixator method of distraction osteogenesis.

Materials and methods {#Sec2}
=====================

Between 1982 and 2009, 25 patients with bone cysts were treated in our hospital with distraction osteogenesis. All patients gave informed consent prior to being included in this retrospective study, which was authorized by the local ethical committee and performed in accordance with the Ethical Standards of the 1964 Declaration of Helsinki as revised in 2000. Mean patient age was 12 (7--18) years. There were 22 boys and three girls. Twenty patients had cysts located in the humerus, three in the femur, one in the distal radius and one in the tibia. Cysts were diagnosed radiologically. Unicameral bone cyst (UBC) was diagnosed in 20 and aneurismal bone cyst (ABC) in five patients. All cases were treated with open and half-open methods, and when the diagnosis was in doubt (22 of 25 patients), radiological diagnosis was confirmed histologically. Eighteen patients had a history of pathological fracture at the same location. Craniocaudal length of the cyst in the axis of the bone was 4--14 (mean 8) cm. Ten patients had active cysts that were in direct contact with the adjacent growth plate (Fig. [1](#Fig1){ref-type="fig"}); 15 had inactive cysts that were found at a distance from the growth plate (Table [1](#Tab1){ref-type="table"}). Indications for surgery were cysts with large cavities, pathological fractures, growth arrest with deformities, length discrepancy of the affected limb, and absence of allograft.Fig. 1X-ray of active unicameral bone cyst (UBC) with pathological fracture of right humerus in a 14-year-old boyTable 1Data of patients, with details of cysts and treatmentPatient no.SexAge\
(years)LocalizationCyst typeActivityPathologic fractureCraniocaudal length of the cyst\
(cm)MethodTime of frame removal\
(months)FunctionFollow-up\
(months)1M10RadiusABCActiveNo4Open4Excellent912M8FemurUBCLatentYes5Closed4Excellent893M14HumerusUBCActiveYes7Open4Excellent894F8HumerusUBCLatentYes7Closed4Excellent875M9HumerusUBCLatentYes7.5Half open4Excellent846M9HumerusUBCLatentYes9Open4Excellent827M11HumerusUBCLatentNo14Open6Excellent758M11HumerusUBCLatentYes6.5Half open4Excellent749M18HumerusUBCLatentYes7Half open4Excellent7410M18HumerusUBCActiveYes10Open6Excellent7311M15HumerusUBCLatentNo11.5Half open4Poor7112M16HumerusABCActiveNo12Open6Excellent6813M14HumerusUBCActiveYes8Open4Excellent4814F12HumerusABCLatentYes11Half open6Excellent4815M10HumerusABCLatentYes5Half open4Excellent4616M7HumerusUBCLatentYes7.5Open4Excellent4517M17HumerusUBCActiveYes7Open4Excellent4418M11HumerusUBCActiveNo9Half open4Excellent4319F11HumerusABCLatentNo7.5Half open4Excellent3720M20HumerusUBCLatentYes5Open4Excellent3621M12FemurUBCActiveYes7Half open4Excellent3422M13HumerusABCLatentYes9Open5Excellent3423M14FemurUBCLatentYes9Closed5Excellent3224M8TibiaUBCActiveNo6Open4Excellent3225M11HumerusUBCActiveYes10Open6Excellent31*ABC* aneurismal bone cyst,*UBC* unicameral bone cyst

All procedures were performed under general anesthesia, with the use of image intensifier or X-ray to localize the cyst and control the position of wires. External fixator wires were inserted proximally and distally and in some cases (six cases) through cystic cavity (for continuous decompression). The external fixator was assembled according to angulatory, translational, and length deformities. Of the 25 patients, we inserted the distal end of the bone to the proximal end by a closed procedure in three patients, a half-open procedure in nine, and an open procedure in remaining 13. We chose the closed method in patients with pathological fracture with a cyst length \<7 cm and radiologically different diameters of proximal and distal fracture ends. The half-open method was used in patients with pathological fracture when fractured ends could not be embedded into each other and in patients with thinned cyst wall but without fracture. We performed osteotomy through a 0.5- to 1-cm incision at the distal end of the cyst that had the smaller diameter. The open method was applied in patients with long cysts (generally \>7 cm) with thick walls and septations, with or without pathological fracture (Fig. [2](#Fig2){ref-type="fig"}). In some of these cases, we performed iatrogenic circular polyfragmented fracture by applying rounded compression with bone forceps, and we used these fragments as local autografts. Curettage was done in patients treated with the open method and was essentially required in patients with cyst septations to create one cystic cavity because isolated cavities prevent proper healing. Relative indication for curettage was an ABC with a soft-tissue component, which was determined by magnetic resonance imaging (MRI) examination. We avoided curettage in patients with active cysts in direct contact with the physis to avoid its damage and consequential deformities and shortenings.Fig. 2**a** X-ray of aneurysmal bone cyst (ABC) of right humerus in a 13-year-old boy. **b** Application of external fixator and open osteotomy and coaptation.**c** Capanna grade 1, completely healed, after 15 months

The amount of shortening depends on the length of the cyst, age of the patient, and presence of limb-length discrepancy. It is preferable to compress the length of the cyst by 1 cm to 50 %, not exceeding 3 cm in order to avoid neurovascular injury. Additional compression with neurovascular status monitoring is possible after operation. Prophylactic hypercorrection was done in patients with active cysts and damaged growth plate in which we anticipated shortening and deformities. In one patient with a cyst length in the bone axis of 14 cm (Fig. [3](#Fig3){ref-type="fig"}), we performed a two-stage monolocal compression distraction osteogenesis, first in the distal and then in the proximal part of the cyst, given the poor infilling of distal and proximal areas of the cystic cavity.Fig. 3**a** X-ray of unicameral bone cyst (UBC) of right humerus in an 11-year-old boy. **b** Application of external fixator and first-level osteotomy with coaptation. **c** Three months after filling the distal part of the cystic cavity, we performed a second proximal-level osteotomy and distraction. **d** Capanna grade 2 healing with residual cavity

In two patients, to enforce and strengthen distraction callus, we intraoperatively added hydroxyapatite ceramic in the cystic cavity, and two other patients postoperatively received bisphosphonate therapy; however, due to their small number, those patients were not included in the analysis.

After 7 days postoperatively, we began distraction with 0.25 mm/three times a day. After limb lengthening and deformity correction, we stopped distraction and fixed the apparatus. After radiological consolidation of newly formed bone was achieved, we removed the frame and the patient began physical therapy. No additional cast or bracing was used.

For radiological evaluation, we used the classification system of Cappana et al. \[[@CR11]\]. This four-part system is based on response to treatment: (1) healed---cyst completely healed, filled with bone, and thickened cortical margins; (2) healed with residual---cyst consolidated with thickened cortex but persistent areas of osteolysis and cortical thinning; (3) recurrence---cyst showed initial consolidation following treatment but subsequently showed zones of osteolysis and cortical thinning; (4) no response---no evidence of cyst healing. For functional assessment we used the modified system of functional evaluation after surgical management of musculoskeletal tumors recommended by Enneking et al. \[[@CR15]\]. This system rating takes into account active range of movement (ROM), pain, stability, deformity, strength, functional activity, and emotional acceptance. For statistical analyses, Kruskal--Wallis test was used to compare means among three groups; Chi-square test was used to compare categorical variables.

Results {#Sec3}
=======

In our study population of 25 bone cysts, 15 (60 %) were classified as completely healed and nine (36 %) as healed with residual radiolucency. Recurrence was observed in one (4 %) patient. Absence of response to treatment was not observed. Median follow-up was 48 (range 31--91) months. In 18 patients, cyst healing and frame removal was within 4 months; in seven patients, this period was 6 months (Table [1](#Tab1){ref-type="table"}). One recurrence was seen 8 months into the postoperative period. The effect of various variables on Capanna outcome is presented in Table [2](#Tab2){ref-type="table"}. Patient age did not influence treatment outcome. Eight patients were ≤10 years, and cysts healed in all cases; 17 patients were \>10 years, recurrence occurred in one patient. Of the ten patients with active cysts, only one experienced recurrence; the 15 patients with latent cysts were healed. Patients with pathological fracture had better outcomes than patients without it. No statistically significant differences in healing time and outcome were noted between closed, half-open, and open treatment. The only recurrence occurred in a patient treated with the half-open method. Functional assessment according to the modified system recommended by Enneking demonstrated excellent functional outcomes in all patients, except one with recurrence, who was rated poor.Table 2Effect of various variables on Capanna outcome \[*n* (%)\]Independent variableCapanna gradeOverall^b^1\
(*n* = 16)2\
(*n* = 8)3\
(*n* = 1)(*n* = 25)Age groups \<115 (62.5)3 (37.5)0 (0.0)8 (32.0) ≥11 and over11 (64.7)5 (29.4)1 (5.9)17 (68.0)Type of cyst Unicameral13 (65.0)6 (30.0)1 (5.0)20 (80.0) Aneurysmal2 (40.0)3 (60.0)0 (0.0)5 (20,0)Activity Active6 (60.0)3 (30.0)1 (10.0)10 (40.0) Latent10 (66.7)5 (33.3)0 (0.0)15 (60.0)Craniocaudal length^a^ (cm)7.22 ± 1.859.31 ± 2.7511.508.06 ± 2.42Pathologic fracture Yes15 (83.3)3 (16.7)0 (0.0)18 (72.0) No1 (14.3)5 (71.4)1 (14.3)7 (28.0)Method Closed3 (100.0)0 (0.0)0 (0.0)3 (12.0) Half open4 (44.2)4 (44.2)1 (11.2)9 (36.0) Open9 (69.2)4 (30.8)0 (0.0)13 (52.0)^a^Means and standard deviations^b^Column percentages are shown among the entire group

Three patients had pin-site infection, which was eliminated by orally administered antibiotic therapy, and one patient with a humeral cyst had radial-nerve neurapraxia, which spontaneously healed in 3 months.

Discussion {#Sec4}
==========

First facts about distraction osteogenesis appeared in the literature in 1905 and were described by Codivilla \[[@CR16]\], who applied the technique to elongate a femur. However, the commonly accepted "father of modern distraction osteogenesis" is G.A. Ilizarov who, in 1951, developed a technique for repairing complex fractures or nonunions of the long bones and, later, started widely applying distraction osteogenesis for treating leg-length discrepancy, nonunion, traumatic bone defects, deformity, and osteomyelitis \[[@CR17]\]. Description of this method in managing musculoskeletal tumors has been presented in the reconstruction of diaphyseal defects after excision of tumors and for arthrodesis after joint resection \[[@CR18]--[@CR20]\].

Application of distraction osteogenesis for managing bone cysts is pathogenically defensible and, in this study, it was dictated by three main principles of treatment: (1) Destroying the fibrous wall of the cyst and, as a result, eliminating the closed cavity using corticotomy and cooptation. (2) Reducing intracystic pressure by creating an iatrogenic fracture, if absent, and inserting Kirschner wires through the cystic lesion. The role of decreased intracystic pressure was demonstrated by Shinozaki et al. \[[@CR21]\], who treated 23 UBCs by drilling multiple holes and inserting Kirschner wires. Overall results of their study showed no recurrences, healing with residual radiolucency in eight patients, and complete healing in 15 patients. Nailing also decompresses the cyst and provides early stability to the bone, with early mobilization and fast recovery to normal activity. Elastic, stable intramedullary nailing for UBC demonstrated good to excellent results in almost all of the 47 UBCs, with long term healing within or during a 36-month period, and complications such as refracture and limb-length discrepancy \[[@CR7]\]. In our study, we observed consolidation and cyst healing within 6 months in almost all patients. (3) Filling the pathological cystic cavity with distraction osteogenesis tissue. This step has two main advantages: it requires no auto- or allograft and simultaneously eliminates deformity and limb-length discrepancy.

Approximately 10 % of patients in our study were at risk of growth arrest from a simple bone cyst. The reason for such arrest has not yet been determined and may be the result of a past fracture associated with the cyst, iatrogenic damage that take place as a result of surgical curettage, or of a simple bone cyst abutting the physis and disrupting the process of direct extension of the cyst through the physial plate into the epiphysis. Avoiding curettage from one side and also the possibility of managing bone length resolves the problem of limb shortening. The need for curettage is still under debate.

Some authors uniquely recommend curettage as a mandatory procedure of treatment \[[@CR8], [@CR22], [@CR23]\]; others never disturb the cyst wall or its membrane \[[@CR9]--[@CR12], [@CR24]\]. In our study, we observed no significant differences in healing time and outcome in patients treated with or without curettage. Curettage and bone grafting have been the traditional treatment of UBC. Oppenheim and Galleno \[[@CR12]\], in 1984, reported a complication rate of 15 % in 37 patients: infection, coxa vara, epiphyseal arrest, and limb shortening. Furthermore, they found a recurrence rate of 40 %. Long periods of immobilization and difficulties obtaining adequate autograft in children are still essential parts of grafting. Besides economic aspects and availability, allograft remains a problem in some countries. Distraction osteogenesis resolves this problem.

A relatively new direction in orthopedic surgery, such as regenerative medicine, holds great promise for managing bone cysts. Instead of filling the cystic cavity with distraction osteogenesis or autograft or allograft material, trends in research revolve around regenerating damaged tissue, as well as stimulating and enhancing the body's own repair mechanisms to heal defects and previously irreparable tissues. Great potential using osteoinductive matrix, osteoprogenitor cells, and recombinant growth factors such as bone morphogenic proteins, bone marrow, stem cells, gene therapy, and the combination of cells with biodegradable scaffolds deliver appropriate bioactive factors that may optimize this regenerative process. Krebsbach et al. \[[@CR25]\] demonstrated in vivo bone formation after using bone-marrow-derived stem cells loaded on extracellular matrices, such as hydroxyapatite--tricalcium phosphate, applied as a scaffold. Regenerative medicine is shaping these new therapies and promising a future treatment modality for bone defects, being deemed to be and area of demand for future research, with the potential to revolutionize bone-cyst treatment.

More than half of bone cysts are first diagnosed as a pathological fracture \[[@CR1]\]. Unlike other methods of treatment, using the method described in this study, we can begin immediate treatment without waiting of fracture healing. Steroid injection remains a widely accepted method of treatment. However, patients had a recurrence rate of 15--88 % after three injections, with limb-length discrepancy being reported in 5--15 % of patients \[[@CR23], [@CR24]\].

Recent studies have reported effectiveness and high healing rates with the use of autologous bone marrow and/or demineralized bone matrix percutaneous infiltration. Di Bella et al. \[[@CR14]\] compared multiple injections of corticosteroids with a single injection of demineralized bone matrix in association with bone marrow concentrate. They demonstrated advantages of higher healing and lower failure rates. Another study \[[@CR26]\] reported better results using a combination injection of steroids, demineralized bone matrix, and bone marrow aspirate in comparison with either injection of steroids or curettage plus bone grafting for UBCs.

Many studies dedicated to managing bone cysts with transosseous osteosynthesis are reported in the Russian Ilizarov Scientific Centre, RISC "RTO" (Kurgan, Russia), where methods such as transverse and longitudinal overlapping, substitution with cortical autografts, etc. were used to restore the cystic cavity. One of the latest studies shows good results (92.3 %) of this treatment in 46 patients with bone cysts \[[@CR27]\].

Despite the large number of research treatment modalities, there is still no established procedure that predicts treatment success. Patient age and cystic activity affects recurrence rates. Patients \>10 years experience cyst healing at a higher rate (90 %) than those \<10 years (60 %), no matter what treatment regimen is utilized \[[@CR28]\]. In our study population, all patients \<10 years had results rated from good to excellent. We also had only one recurrence, which was in a patient with an active cyst.

This study has several limitations: Despite many common features of UBC and ABC, they are two distinct, nosologic entities and show some differences in clinical behavior. It would be better to evaluate them separately. However, the similar positive results inclined us to publish them together, although we strongly recommend more aggressive treatment, with curettage and open methods for ABC in comparison with UBC. The number of patients was not adequate to conduct many of the statistical analyses, as this treatment method is not widely used. To analyze the impact of various variables on the Capanna outcome, studies with a higher number of patients or meta-analyses of studies like ours could be conducted.

Despite the fact that bone cysts were discovered about 100 years ago, they remain a persistent challenge for the treating physician. Multiple treatment options have recently been presented, but no single treatment has been established as being the best, and there is still no gold standard their management. As simple bone cysts are found in long bones in 90--95 % of patients, and taking into account our achieved positive results in almost all patients in this study, we can recommend distraction osteogenesis as a treatment option. The effectiveness of this method is the low rate of recurrences during the short period of treatment (4--6 months); simultaneous elimination of limb shortening and deformities; in the presence of pathological fracture, the ability to initiate prompt treatment without waiting for the fracture to heal; and return to normal activity in a shorter period. The economic benefits are cyst cavity restoration by the patient's own body, and avoiding allograft with its associated cost---which remains a problem in some countries.

None.
